CIK 0000899460
- Large accelerated filer
MANNKIND CORP
Sign in to watch- Ticker
- MNKD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133607736
- Phone
- +1 818-661-5000
- Business address
- 1 CASPER STREET, DANBURY, CT, 06810
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief People & Workpl Officer acquired 147,717 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 147,895 shares (grant or award)
- 4 Grant or award EVP Genl Counsel & Secretary acquired 148,412 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 148,074 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 416,092 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 144,000 shares (grant or award)
- 4 Open-market buy Chief Executive Officer bought 3,000 shares at $3.38 ($10,140)
- 4 Open-market buy Chief Financial Officer bought 1,557 shares at $1.33 ($2,071)
- 4 Open-market buy Chief People & Workpl Officer bought 5,000 shares at $1.33 ($6,650)
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $1.33 ($6,650)
- 4 Shares withheld for taxes Chief People & Workpl Officer gave up 1,729 shares (to pay taxes)
- 4/A Open-market buy Chief Commercial Officer bought 34,602 shares at $2.89 ($100,000)
- 4 Open-market buy Chief Commercial Officer bought 34,602 shares at $2.89 ($100,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 14 of 50 · 999 filings